Radiofrequency Catheter Ablation For Atrial Fibrillation: Approaches And Outcomes

Heart Lung and Circulation

Volumn 26, Issue 9, 2017, Pages 941-949

  Kalla, Manish ^a   Sanders, Prashanthan ^b   Kalman, Jonathan M ^a   Lee, Geoffrey ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Atrial fibrillation; Catheter ablation; Cryoballoon; Outcomes; Radiofrequency

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARRHYTHMOGENESIS; BLOOD VESSEL FUNCTION; CARDIOVASCULAR RISK; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CRYOABLATION; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PAROXYSMAL ATRIAL FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VEIN; QUALITY OF LIFE; RETREATMENT; REVIEW; RISK MANAGEMENT; SYMPTOM; TREATMENT INDICATION; ATRIAL FIBRILLATION; HEART MUSCLE CONDUCTION SYSTEM; PROCEDURES; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; HEART CONDUCTION SYSTEM; HUMANS; TREATMENT OUTCOME;

EID: 85022049037     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2017.05.125     Document Type: Review

References (89)

1. Calkins, H., Kuck, K.H., Cappato, R., Brugada, J., Camm, A.J., Chen, S.A., et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the heart rhythm society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society Of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College Of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society Of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College Of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society Of Thoracic Surgeons, the asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm, 9, 2012 632–696 e621.
2. Hohnloser, S.H., Kuck, K.H., Lilienthal, J., Rhythm or rate control in atrial fibrillation–pharmacological intervention in atrial fibrillation (PIAF): A randomised trial. Lancet 356 (2000), 1789–1794.
3. Singh, B.N., Singh, S.N., Reda, D.J., Tang, X.C., Lopez, B., Harris, C.L., et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352 (2005), 1861–1872.
4. Van Gelder, I.C., Hagens, V.E., Bosker, H.A., Kingma, J.H., Kamp, O., Kingma, T., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002), 1834–1840.
5. Wyse, D.G., Rhythm management in atrial fibrillation: Less is more. J Am Coll Cardiol 41 (2003), 1703–1706.
6. Wazni, O.M., Marrouche, N.F., Martin, D.O., Verma, A., Bhargava, M., Saliba, W., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 293 (2005), 2634–2640.
7. Stabile, G., Bertaglia, E., Senatore, G., De Simone, A., Zoppo, F., Donnici, G., et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study). Eur Heart J 27 (2006), 216–221.
8. Pappone, C., Augello, G., Sala, S., Gugliotta, F., Vicedomini, G., Gulletta, S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF study. J Am Coll Cardiol 48 (2006), 2340–2347.
9. Wilber, D.J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 303 (2010), 333–340.
10. Calkins, H., Reynolds, M.R., Spector, P., Sondhi, M., Xu, Y., Martin, A., et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2 (2009), 349–361.
11. Bonanno, C., Paccanaro, M., La Vecchia, L., Ometto, R., Fontanelli, A., Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: A meta-analysis of randomized trials. J Cardiovasc Med (Hagerstown) 11 (2010), 408–418.
12. Schotten, U., Verheule, S., Kirchhof, P., Goette, A., Pathophysiological mechanisms of atrial fibrillation: A translational appraisal. Physiol Rev 91 (2011), 265–325.
13. Csepe, T.A., Hansen, B.J., Fedorov, V.V., Atrial fibrillation driver mechanisms: Insight from the isolated human heart. Trends Cardiovasc Med 27 (2017), 1–11.
14. Lee, G., Kumar, S., Teh, A., Madry, A., Spence, S., Larobina, M., et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: Transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J 35 (2014), 86–97.
15. Walters, T.E., Lee, G., Spence, S., Kalman, J.M., The effect of electrode density on the interpretation of atrial activation patterns in epicardial mapping of human persistent atrial fibrillation. Heart Rhythm 13 (2016), 1215–1220.
16. de Groot, N.M., Houben, R.P., Smeets, J.L., Boersma, E., Schotten, U., Schalij, M.J., et al. Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: Epicardial breakthrough. Circulation 122 (2010), 1674–1682.
17. Moe, G.K., Rheinboldt, W.C., Abildskov, J.A., A computer model of atrial fibrillation. Am Heart J 67 (1964), 200–220.
18. Haissaguerre, M., Jais, P., Shah, D.C., Takahashi, A., Hocini, M., Quiniou, G., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998), 659–666.
19. Chen, S.A., Hsieh, M.H., Tai, C.T., Tsai, C.F., Prakash, V.S., Yu, W.C., et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100 (1999), 1879–1886.
20. Shah, D., Haissaguerre, M., Jais, P., Hocini, M., Nonpulmonary vein foci: Do they exist?. Pacing Clin Electrophysiol 26 (2003), 1631–1635.
21. Chen, Y.J., Chen, S.A., Chen, Y.C., Yeh, H.I., Chan, P., Chang, M.S., et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: Implication in initiation of atrial fibrillation. Circulation 104 (2001), 2849–2854.
22. Patterson, E., Jackman, W.M., Beckman, K.J., Lazzara, R., Lockwood, D., Scherlag, B.J., et al. Spontaneous pulmonary vein firing in man: Relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro. J Cardiovasc Electrophysiol 18 (2007), 1067–1075.
23. 2+ leak and increased na+-ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125 (2012), 2059–2070.
24. Arora, R., Verheule, S., Scott, L., Navarrete, A., Katari, V., Wilson, E., et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 107 (2003), 1816–1821.
25. Verheule, S., Wilson, E.E., Arora, R., Engle, S.K., Scott, L.R., Olgin, J.E., Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res 55 (2002), 727–738.
26. Lee, G., Roberts-Thomson, K., Madry, A., Spence, S., Teh, A., Heck, P.M., et al. Relationship among complex signals, short cycle length activity, and dominant freque ncy in patients with long-lasting persistent af: A high-density epicardial mapping study in humans. Heart Rhythm 8 (2011), 1714–1719.
27. Ho, S.Y., Sanchez-Quintana, D., Cabrera, J.A., Anderson, R.H., Anatomy of the left atrium: Implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 10 (1999), 1525–1533.
28. Vaitkevicius, R., Saburkina, I., Rysevaite, K., Vaitkeviciene, I., Pauziene, N., Zaliunas, R., et al. Nerve supply of the human pulmonary veins: An anatomical study. Heart Rhythm 6 (2009), 221–228.
29. Nattel, S., Burstein, B., Dobrev, D., Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circ Arrhythm Electrophysiol 1 (2008), 62–73.
30. Teh, A.W., Kistler, P.M., Lee, G., Medi, C., Heck, P.M., Spence, S.J., et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol 23 (2012), 232–238.
31. Kistler, P.M., Sanders, P., Fynn, S.P., Stevenson, I.H., Spence, S.J., Vohra, J.K., et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol 44 (2004), 109–116.
32. Sanders, P., Morton, J.B., Davidson, N.C., Spence, S.J., Vohra, J.K., Sparks, P.B., et al. Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans. Circulation 108 (2003), 1461–1468.
33. Mahajan, R., Lau, D.H., Brooks, A.G., Shipp, N.J., Manavis, J., Wood, J.P., et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 66 (2015), 1–11.
34. Medi, C., Kalman, J.M., Spence, S.J., Teh, A.W., Lee, G., Bader, I., et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: Implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol 22 (2011), 1317–1324.
35. Kumar, S., Teh, A.W., Medi, C., Kistler, P.M., Morton, J.B., Kalman, J.M., Atrial remodeling in varying clinical substrates within beating human hearts: Relevance to atrial fibrillation. Prog Biophys Mol Biol 110 (2012), 278–294.
36. Dimitri, H., Ng, M., Brooks, A.G., Kuklik, P., Stiles, M.K., Lau, D.H., et al. Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation. Heart Rhythm 9 (2012), 321–327.
37. Gray, R.A., Pertsov, A.M., Jalife, J., Spatial and temporal organization during cardiac fibrillation. Nature 392 (1998), 75–78.
38. Sahadevan, J., Ryu, K., Peltz, L., Khrestian, C.M., Stewart, R.W., Markowitz, A.H., et al. Epicardial mapping of chronic atrial fibrillation in patients: Preliminary observations. Circulation 110 (2004), 3293–3299.
39. Narayan, S.M., Krummen, D.E., Rappel, W.J., Clinical mapping approach to diagnose electrical rotors and focal impulse sources for human atrial fibrillation. J Cardiovasc Electrophysiol 23 (2012), 447–454.
40. Lee, G., Spence, S., Teh, A., Goldblatt, J., Larobina, M., Atkinson, V., et al. High-density epicardial mapping of the pulmonary vein-left atrial junction in humans: Insights into mechanisms of pulmonary vein arrhythmogenesis. Heart Rhythm 9 (2012), 258–264.
41. Haissaguerre, M., Hocini, M., Denis, A., Shah, A.J., Komatsu, Y., Yamashita, S., et al. Driver domains in persistent atrial fibrillation. Circulation 130 (2014), 530–538.
42. Narayan, S.M., Krummen, D.E., Shivkumar, K., Clopton, P., Rappel, W.J., Miller, J.M., Treatment of atrial fibrillation by the ablation of localized sources: Confirm (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. J Am Coll Cardiol 60 (2012), 628–636.
43. Steinberg, J.S., Shah, Y., Bhatt, A., Sichrovsky, T., Arshad, A., Hansinger, E., et al. Focal impulse and rotor modulation: Acute procedural observations and extended clinical follow-up. Heart Rhythm 14 (2017), 192–197.
44. Hansen, B.J., Zhao, J., Csepe, T.A., Moore, B.T., Li, N., Jayne, L.A., et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J 36 (2015), 2390–2401.
45. Lee, G., Sanders, P., Kalman, J.M., Catheter ablation of atrial arrhythmias: State of the art. Lancet 380 (2012), 1509–1519.
46. Brooks, A.G., Stiles, M.K., Laborderie, J., Lau, D.H., Kuklik, P., Shipp, N.J., et al. Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review. Heart Rhythm 7 (2010), 835–846.
47. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, et al., 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm, (in press), doi: http://dx.doi.org/10.1016/j.hrthm.2017.05.012.
48. Jais, P., Haissaguerre, M., Shah, D.C., Chouairi, S., Gencel, L., Hocini, M., et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95 (1997), 572–576.
49. Hocini, M., Jais, P., Sanders, P., Takahashi, Y., Rotter, M., Rostock, T., et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: A prospective randomized study. Circulation 112 (2005), 3688–3696.
50. Deisenhofer, I., Estner, H., Reents, T., Fichtner, S., Bauer, A., Wu, J., et al. Does electrogram guided substrate ablation add to the success of pulmonary vein isolation in patients with paroxysmal atrial fibrillation? A prospective, randomized study. J Cardiovasc Electrophysiol 20 (2009), 514–521.
51. Mikhaylov, E., Kanidieva, A., Sviridova, N., Abramov, M., Gureev, S., Szili-Torok, T., et al. Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation: A 3-year follow-up study. Europace 13 (2011), 362–370.
52. Lee, G., Hunter, R.J., Lovell, M.J., Finlay, M., Ullah, W., Baker, V., et al. Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation. Europace 18 (2016), 211–218.
53. Ullah, W., McLean, A., Tayebjee, M.H., Gupta, D., Ginks, M.R., Haywood, G.A., et al. Randomized trial comparing pulmonary vein isolation using the smarttouch catheter with or without real-time contact force data. Heart Rhythm 13 (2016), 1761–1767.
54. Voskoboinik, A., Kalman, E.S., Savicky, Y., Sparks, P.B., Morton, J.B., Lee, G., et al. Reduction in radiation dose for atrial fibrillation ablation over time: A 12 year single centre experience of 2,344 patients. Heart Rhythm, 2017.
55. Neumann, T., Vogt, J., Schumacher, B., Dorszewski, A., Kuniss, M., Neuser, H., et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 52 (2008), 273–278.
56. Van Belle, Y., Janse, P., Theuns, D., Szili-Torok, T., Jordaens, L., One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace 10 (2008), 1271–1276.
57. Scharf, C., Boersma, L., Davies, W., Kanagaratnam, P., Peters, N.S., Paul, V., et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol 54 (2009), 1450–1456.
58. Linhart, M., Bellmann, B., Mittmann-Braun, E., Schrickel, J.W., Bitzen, A., Andrie, R., et al. Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: A case-control study. J Cardiovasc Electrophysiol 20 (2009), 1343–1348.
59. Furnkranz, A., Koster, I., Chun, K.R., Metzner, A., Mathew, S., Konstantinidou, M., et al. Cryoballoon temperature predicts acute pulmonary vein isolation. Heart Rhythm 8 (2011), 821–825.
60. Sacher, F., Monahan, K.H., Thomas, S.P., Davidson, N., Adragao, P., Sanders, P., et al. Phrenic nerve injury after atrial fibrillation catheter ablation: Characterization and outcome in a multicenter study. J Am Coll Cardiol 47 (2006), 2498–2503.
61. Kuck, K.H., Brugada, J., Furnkranz, A., Metzner, A., Ouyang, F., Chun, K.R., et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374 (2016), 2235–2245.
62. Kalman, J.M., Sanders, P., Atrial fibrillation: Fire or ice? Cryoablation not inferior, not superior. Nat Rev Cardiol 13 (2016), 572–574.
63. Gerstenfeld, E.P., Callans, D.J., Dixit, S., Zado, E., Marchlinski, F.E., Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: Implications for ablation strategies. J Cardiovasc Electrophysiol 14 (2003), 685–690.
64. Ouyang, F., Tilz, R., Chun, J., Schmidt, B., Wissner, E., Zerm, T., et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up. Circulation 122 (2010), 2368–2377.
65. Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42 (2003), 185–197.
66. Bhargava, M., Di Biase, L., Mohanty, P., Prasad, S., Martin, D.O., Williams-Andrews, M., et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: Results from a multicenter study. Heart Rhythm 6 (2009), 1403–1412.
67. Wokhlu, A., Hodge, D.O., Monahan, K.H., Asirvatham, S.J., Friedman, P.A., Munger, T.M., et al. Long-term outcome of atrial fibrillation ablation: Impact and predictors of very late recurrence. J Cardiovasc Electrophysiol 21 (2010), 1071–1078.
68. Weerasooriya, R., Khairy, P., Litalien, J., Macle, L., Hocini, M., Sacher, F., et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up?. J Am Coll Cardiol 57 (2011), 160–166.
69. Arya, A., Hindricks, G., Sommer, P., Huo, Y., Bollmann, A., Gaspar, T., et al. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 12 (2010), 173–180.
70. Verma, A., Jiang, C.Y., Betts, T.R., Chen, J., Deisenhofer, I., Mantovan, R., et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372 (2015), 1812–1822.
71. Daoud, E.G., Weiss, R., Augostini, R., Hummel, J.D., Kalbfleisch, S.J., Van Deren, J.M., et al. Proarrhythmia of circumferential left atrial lesions for management of atrial fibrillation. J Cardiovasc Electrophysiol 17 (2006), 157–165.
72. Narayan, S.M., Baykaner, T., Clopton, P., Schricker, A., Lalani, G.G., Krummen, D.E., et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: Extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). J Am Coll Cardiol 63 (2014), 1761–1768.
73. Miller, J.M., Kowal, R.C., Swarup, V., Daubert, J.P., Daoud, E.G., Day, J.D., et al. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: Multicenter FIRM registry. J Cardiovasc Electrophysiol 25 (2014), 921–929.
74. Buch, E., Share, M., Tung, R., Benharash, P., Sharma, P., Koneru, J., et al. Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: A multicenter experience. Heart Rhythm 13 (2016), 636–641.
75. Rolf, S., Kircher, S., Arya, A., Eitel, C., Sommer, P., Richter, S., et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 7 (2014), 825–833.
76. Bisleri, G., Glover, B., Hybrid ablation for atrial fibrillation: Current approaches and future directions. Curr Opin Cardiol 32 (2017), 17–21.
77. Bertaglia, E., Zoppo, F., Tondo, C., Colella, A., Mantovan, R., Senatore, G., et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety. Heart Rhythm 4 (2007), 1265–1271.
78. Spragg, D.D., Dalal, D., Cheema, A., Scherr, D., Chilukuri, K., Cheng, A., et al. Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol 19 (2008), 627–631.
79. Hoyt, H., Bhonsale, A., Chilukuri, K., Alhumaid, F., Needleman, M., Edwards, D., et al. Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors. Heart Rhythm 8 (2011), 1869–1874.
80. Lee, G., Sparks, P.B., Morton, J.B., Kistler, P.M., Vohra, J.K., Medi, C., et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: Results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol 22 (2011), 163–168.
81. Marijon, E., Fazaa, S., Narayanan, K., Guy-Moyat, B., Bouzeman, A., Providencia, R., et al. Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation: Procedural and 1-year results. J Cardiovasc Electrophysiol 25 (2014), 130–137.
82. Andrade, J.G., Monir, G., Pollak, S.J., Khairy, P., Dubuc, M., Roy, D., et al. Pulmonary vein isolation using “contact force” ablation: The effect on dormant conduction and long-term freedom from recurrent atrial fibrillation–a prospective study. Heart Rhythm 11 (2014), 1919–1924.
83. Kerst, G., Weig, H.J., Weretka, S., Seizer, P., Hofbeck, M., Gawaz, M., et al. Contact force-controlled zero-fluoroscopy catheter ablation of right-sided and left atrial arrhythmia substrates. Heart Rhythm 9 (2012), 709–714.
84. Kuck, K.H., Reddy, V.Y., Schmidt, B., Natale, A., Neuzil, P., Saoudi, N., et al. A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm 9 (2012), 18–23.
85. Nattel, S., Dobrev, D., Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol 13 (2016), 575–590.
86. Anter, E., Tschabrunn, C.M., Contreras-Valdes, F.M., Li, J., Josephson, M.E., Pulmonary vein isolation using the rhythmia mapping system: Verification of intracardiac signals using the orion mini-basket catheter. Heart Rhythm 12 (2015), 1927–1934.
87. Pathak, R.K., Middeldorp, M.E., Lau, D.H., Mehta, A.B., Mahajan, R., Twomey, D., et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study. J Am Coll Cardiol 64 (2014), 2222–2231.
88. Pathak, R.K., Middeldorp, M.E., Meredith, M., Mehta, A.B., Mahajan, R., Wong, C.X., et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY). J Am Coll Cardiol 65 (2015), 2159–2169.
89. Walfridsson, H., Walfridsson, U., Nielsen, J.C., Johannessen, A., Raatikainen, P., Janzon, M., et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: Results on health-related quality of life and symptom burden. The MANTRA-PAF trial. Europace 17 (2015), 215–221.